BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25564210)

  • 1. Improving decision-making regarding oesophagectomy after preoperative therapy.
    Kidane B; Darling GE
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):461-2. PubMed ID: 25564210
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical predictors of early cancer-related mortality following neoadjuvant therapy and oesophagectomy.
    Stiles BM; Salzler GG; Nasar A; Paul S; Lee PC; Port JL; Altorki NK
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):455-60; discussion 460-1. PubMed ID: 25564218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis.
    Hölscher AH; Bollschweiler E; Bogoevski D; Schmidt H; Semrau R; Izbicki JR
    Eur J Cancer; 2014 Nov; 50(17):2950-7. PubMed ID: 25307749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy.
    Lagarde SM; Navidi M; Gisbertz SS; van Laarhoven HW; Sumpter K; Meijer SL; Disep B; Immanuel A; Griffin SM; van Berge Henegouwen MI
    Br J Surg; 2016 Nov; 103(12):1658-1664. PubMed ID: 27696382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcome of Esophagectomy in Elderly Patients With and Without Neoadjuvant Therapy for Thoracic Esophageal Cancer.
    Miyata H; Yamasaki M; Makino T; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S794-801. PubMed ID: 26224407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?
    Fogh SE; Yu A; Kubicek GJ; Scott W; Mitchell E; Rosato EL; Berger AC
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1372-6. PubMed ID: 21106309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study.
    van der Werf LR; Dikken JL; van der Willik EM; van Berge Henegouwen MI; Nieuwenhuijzen GAP; Wijnhoven BPL;
    Eur J Cancer; 2018 Mar; 91():76-85. PubMed ID: 29353163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery.
    Reisinger KW; Bosmans JW; Uittenbogaart M; Alsoumali A; Poeze M; Sosef MN; Derikx JP
    Ann Surg Oncol; 2015 Dec; 22(13):4445-52. PubMed ID: 25893413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the benefit of a pathologic complete response after neoadjuvant chemoradiotherapy in the treatment of esophageal cancer.
    Scheer RV; Fakiris AJ; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):996-1001. PubMed ID: 20584580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation.
    Spector R; Zheng Y; Yeap BY; Wee JO; Lebenthal A; Swanson SJ; Marchosky DE; Enzinger PC; Mamon HJ; Lerut A; Odze R; Srivastava A; Agoston AT; Tippayawang M; Bueno R;
    Semin Thorac Cardiovasc Surg; 2015; 27(2):205-15. PubMed ID: 26686448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis.
    Pasquali S; Yim G; Vohra RS; Mocellin S; Nyanhongo D; Marriott P; Geh JI; Griffiths EA
    Ann Surg; 2017 Mar; 265(3):481-491. PubMed ID: 27429017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy.
    Miyata H; Yamasaki M; Makino T; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    J Surg Oncol; 2015 Jul; 112(1):60-5. PubMed ID: 26179950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer.
    de Heer EC; Hulshoff JB; Klerk D; Burgerhof JGM; de Groot DJA; Plukker JTM; Hospers GAP
    Ann Surg Oncol; 2017 Jul; 24(7):1811-1820. PubMed ID: 28188501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophagectomy after chemoradiation: who and when to operate.
    Kim JY; Hofstetter WL
    Semin Thorac Cardiovasc Surg; 2012; 24(4):288-93. PubMed ID: 23465677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive versus open oesophagectomy for cancer: propensity score analysis improves results' reliability but matching criteria need to be selected accurately.
    Giulini L; Dubecz A
    Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35349668
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study.
    Markar SR; Gronnier C; Pasquer A; Duhamel A; Beal H; Théreaux J; Gagnière J; Lebreton G; Brigand C; Meunier B; Collet D; Mariette C;
    Eur J Cancer; 2016 Mar; 56():59-68. PubMed ID: 26808298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interval between neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma: does delayed surgery impact outcome?
    Chiu CH; Chao YK; Chang HK; Tseng CK; Chan SC; Liu YH; Chen WH
    Ann Surg Oncol; 2013 Dec; 20(13):4245-51. PubMed ID: 23959050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway colonisation and postoperative pulmonary complications after neoadjuvant therapy for oesophageal cancer.
    D'Journo XB; Michelet P; Papazian L; Reynaud-Gaubert M; Doddoli C; Giudicelli R; Fuentes PA; Thomas PA
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):444-50. PubMed ID: 18249002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of neoadjuvant chemoradiotherapy on perioperative outcomes, tumor pathology, and survival in clinical stage II and III esophageal cancer.
    Markar SR; Bodnar A; Rosales J; Song G; Low DE
    Ann Surg Oncol; 2013 Nov; 20(12):3935-41. PubMed ID: 23892525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
    Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
    World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.